Syra Health Corp. SYRA
$0.91
$0.022.25%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.03% | 22.38% | -13.59% | -25.09% | -1.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.03% | 22.38% | -13.59% | -25.09% | -1.19% |
| Cost of Revenue | 11.30% | 2.66% | -31.64% | -28.49% | -26.33% |
| Gross Profit | 41.63% | 64.85% | 76.53% | -17.03% | 115.11% |
| SG&A Expenses | -1.77% | -24.17% | -13.18% | -24.72% | -46.00% |
| Depreciation & Amortization | -88.33% | -83.82% | -68.49% | -78.82% | -65.52% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.64% | -10.66% | -25.46% | -28.41% | -40.20% |
| Operating Income | 498.10% | 140.35% | 72.95% | 45.86% | 95.45% |
| Income Before Tax | 493.40% | 151.03% | 73.31% | 45.89% | 95.43% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 493.40% | 151.03% | 73.31% | 45.89% | 95.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 493.40% | 151.03% | 73.31% | 45.89% | 95.43% |
| EBIT | 498.10% | 140.35% | 72.95% | 45.86% | 95.45% |
| EBITDA | 345.52% | 141.16% | 73.64% | 43.78% | 104.30% |
| EPS Basic | 458.49% | 149.51% | 77.97% | 67.13% | 97.48% |
| Normalized Basic EPS | 460.61% | 149.41% | 78.13% | 67.13% | 97.49% |
| EPS Diluted | 290.00% | 149.02% | 77.97% | 67.13% | 95.25% |
| Normalized Diluted EPS | 448.48% | 146.27% | 78.13% | 67.13% | 97.49% |
| Average Basic Shares Outstanding | 10.35% | 3.04% | 21.36% | 64.34% | 80.83% |
| Average Diluted Shares Outstanding | 13.51% | 10.31% | 21.36% | 64.34% | 80.83% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |